JeNaCell produces biotechnologically generated nanocellulose (BNC) in an IP protected, continuous and automated production process: high quality innovative products for applications in medicine, cosmetics and more.
Additional financing for JeNaCell: Investors once again back platform technology for the production of high-tech bio-material
The Jena biotech company successfully raises further venture capital in a Series A financing. The funds will be used for the expansion of its production capacity and the extension of its distribution network. JeNaCell is a specialist for biotechnologically produced…
JeNaCell Receives Seed Financing from High-Tech Gründerfonds and STIFT
High-Tech Gründerfonds and STIFT are jointly investing €700,000 in JeNaCell GmbH. The capital will be used to build up automated production in the creation of a high-performance, high-tech biomaterial. The business idea of JeNaCell GmbH, a spin-off of the Friedrich Schiller University in Jena, Germany, is based…
14. Sep 2012